MGH Center for Women's Mental Health

Depression and Menopausal Symptoms Go Together

It is well established that women are at increased risk for developing depression compared to men. It has been hypothesized that this vulnerability to depression may be hormonally mediated, and several longitudinal studies have documented an increased risk of depressive symptoms during perimenopause or the menopausal transition. Based on the results of two prospective cohort studies, approximately one-third of women will develop their first episode of depression during the menopausal transition. (Cohen LS et al 2006, Freeman EW et al 2006).

By MGH Center for Women's Mental Health|2015-08-12T14:58:10-04:00August 17th, 2009|Depressive Disorders, Menopausal Symptoms, Prevalence & Risk Factors|Comments Off

Generic Medications

Many patients ask questions about generic medications, wondering how they differ and if they’re as safe and as effective as the more expensive brand name versions. To better understand this concept, we’ll discuss an example.

By MGH Center for Women's Mental Health|2015-08-12T14:56:26-04:00August 10th, 2009|Antidepressants, General, Medication|Comments Off

Prepregnancy Depressive Mood is a Risk Factor for Preterm Birth

There have been multiple studies suggesting that depression during pregnancy increases the risk for preterm labor. Most studies do not attribute this increase in risk to antidepressant exposure, but to the effects of the depression itself. The mechanism is believed to be related to increased levels of corticotropin releasing hormone (CRH) which is triggered by stress. Elevated levels of CRH have been shown to be a predictor of preterm birth.

By MGH Center for Women's Mental Health|2015-08-12T14:53:20-04:00July 28th, 2009|Depressive Disorders, Outcomes, Pregnancy Outcomes, Psychiatric Disorders During Pregnancy|Comments Off

Mental Health Parity in Massachusetts

Recent changes expanded the scope of mental health parity in the Commonwealth of Massachusetts, which requires insurance companies to cover specified diagnoses on a “nondiscriminatory basis”. This means that copayments, deductibles, coinsurance, unit of service limits- such as hospital days and outpatient visits, and/or annual or lifetime maximums are no greater for mental disorders when compared to physical conditions.

By MGH Center for Women's Mental Health|2015-08-12T14:51:49-04:00July 16th, 2009|Advocacy, General|Comments Off

What Would You Do? A Pregnant Women on Duloxetine (Cymbalta)

Ms. A is a 27-year-old woman who is seven weeks pregnant and is currently taking duloxetine (Cymbalta). She has a history of recurrent major depressive disorder (MDD) and has had a good response to duloxetine at 60 mg per day. She has had four previous episodes of major depressive disorder (most untreated) and has been in remission for one year. Past episodes have lasted up to six months and caused difficulty with functioning at work and in relationships, although she was not diagnosed and treated until one year ago.

By MGH Center for Women's Mental Health|2015-08-12T14:50:32-04:00June 29th, 2009|Antidepressants, Pregnancy & Medications|Comments Off

Do SSRIs Increase the Risk of Preeclampsia?

Hypertension in pregnancy is generally defined as a diastolic blood pressure of 90 mm Hg or greater or a systolic pressure at or above 140 mm Hg. Preeclampsia is defined as the development of hypertension with proteinuria or edema induced by pregnancy, generally in the second half of gestation. It is more common in women who have not carried a previous pregnancy beyond 20 weeks and in women at the extremes of the reproductive years.

By MGH Center for Women's Mental Health|2015-07-28T11:31:33-04:00June 22nd, 2009|Antidepressants, Pregnancy & Medications, Pregnancy Outcomes|Comments Off

Omega-3 Fatty Acids for Depression in Women

An ideal treatment for major depressive disorder (MDD) in women would be efficacious, safe, and offer broad health benefits. MDD is prevalent in women of childbearing years, and recent research underscores the risk of recurrence [...]

By MGH Center for Women's Mental Health|2020-12-11T12:39:30-04:00June 19th, 2009|Alternative & Complementary, Depressive Disorders, General, Treatment|Comments Off

OCD in Pregnant and Postpartum Women

The lifetime prevalence rate of obsessive-compulsive disorder (OCD) has been consistently estimated to be 2%-3% in the general adult population throughout the world, making OCD one of more common psychiatric diagnoses; however research on OCD in pregnancy and peurperium has been limited.

By MGH Center for Women's Mental Health|2015-08-12T14:45:14-04:00June 18th, 2009|Anxiety Disorders, Postpartum Psychiatric Disorders, Prevalence & Risk Factors, Psychiatric Disorders During Pregnancy|Comments Off

Use of Complementary and Alternative Medicines for Menopausal Hot Flashes

Approximately seventy percent of all women experience hot flashes and/or night sweats (also called vasomotor symptoms) during the menopause transition (Stearns et al. 2002). Until recently, estrogen therapy was the treatment of choice for most women who sought treatment for hot flashes. Since the results of the Women's Health Initiative in 2002 noted risks of prolonged use of hormone therapy in older postmenopausal women (Roussouw et al. 2002), many women pursue other treatments for their hot flashes, including over-the-counter complementary and alternative medicines (CAMs), including soy isoflavones, black cohosh, and omega-3 fatty acids. However, there is limited evidence to support the use of these treatments for hot flashes to date.

By MGH Center for Women's Mental Health|2015-08-12T14:41:43-04:00May 29th, 2009|Alternative & Complementary, Menopausal Symptoms, Treatment, Vasomotor Symptoms|Comments Off

Postpartum Depressive Symptoms Increase the Risk of Smoking Relapse

While many women who smoke successfully quit smoking during pregnancy, most of these women return to smoking within 12 months of delivery. Several studies have suggested that certain factors may increase the risk of postpartum relapse, including unwanted pregnancy, multiparity, and stressful life events. Two recent studies indicate that postpartum depressive symptoms may also increase the risk of smoking relapse after delivery.

By MGH Center for Women's Mental Health|2016-03-28T13:23:58-04:00May 19th, 2009|Nicotine, Perinatal Substance Use, Postpartum Depression, Postpartum Psychiatric Disorders, Prevalence & Risk Factors|Comments Off

About MGH Center for Women's Mental Health